BSECompany Update13 Oct 2026 · 13 Oct 2026, 04:12 pm

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half year ended September 30, 2026.

Pharmaids Pharmaceuticals Ltd · 524572

✦ AI Summary

Pharmaids Pharmaceuticals Ltd has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the completion of dematerialization of shares for the quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Pharmaids Pharmaceuticals Ltd - 524572 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attachments (1)

📄

9b4bb9a6-a26c-4227-ba40-1e2805468282.pdf

pdf

Download →
View document text
Date:13.10.2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001 Dear Sir/Madam, BSE Scrip: PHARMAID | Code: 524572 ISIN: INE117D01018 Sub: Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter and Half Year ended September 30, 2026. Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, please find enclosed herewith the Certificate received from M/s Venture Capital and Corporate Investments Private Limited (SEBI Registration No. INR000001203), Registrar and Share Transfer Agent of the Company, for the Quarter and Half Year ended September 30, 2026, confirming the compliances completed with respect to dematerialization of the shares, in terms of the said Regulation. This is for your information and records. For Pharmaids Pharmaceuticals Limited Prasanna Subramanya Bhat (Company Secretary & Compliance Officer) PHARMAIDS PHARMACEUTICALS LIMITED (CIN: L52520KA1989PLC173979) Registered Office.: Unit #201, Brigade Rubix, 20/14, HMT Factory Road, Peenya Plantation, Bangalore 560013 INDIA Phone:080-49784319 Email: compliance@pharmaids.com WEB: www.pharmaids.com Date: 05.10.2026 The Company Secretary, Pharmaids Pharmaceuticals Limited, Unit # 201, Brigade Rubix, 20/14, HMT Factory Road, Peenya Plantation, Bangalore – 560013. Dear Sir/Madam, Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30.09.2026 Ref: Security Code - 524572 ISIN: INE117D01018 We hereby certify that the securities received for dematerialization have been mutilated and cancelled after due verification and the name of the depositories (National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) has been updated in the records of company as the registered owner within 15 days of receipt of valid DRF & Share certificate of said company and the details of securities are furnished to the stock exchange(s). We request you to take this information on record and to inform Depositories(s) and Stock Exchange(s) wherever your securities are listed accordingly. Thanking you, Yours faithfully, for Venture Capital and Corporate Investments Private Limited Authorized Signatory.